Cresco Labs Secures $325 Million Refinancing to Boost Growth

Cresco Labs ( (TSE:CL) ) has issued an update.

Cresco Labs has successfully closed a $325 million senior secured term loan refinancing, extending the maturity to 2030 and strengthening its balance sheet. This move reduces the company’s total debt and provides flexibility for prepayment, positioning Cresco Labs for future growth and reducing near-term refinancing risks. The transaction reflects the company’s disciplined capital management strategy and supports its ongoing growth plans.

The most recent analyst rating on (TSE:CL) stock is a Buy with a C$2.80 price target. To see the full list of analyst forecasts on Cresco Labs stock, see the TSE:CL Stock Forecast page.

Spark’s Take on TSE:CL Stock

According to Spark, TipRanks’ AI Analyst, TSE:CL is a Neutral.

Cresco Labs’ overall stock score reflects a mixed outlook. The company’s financial performance shows improvement in cash flow and operational efficiency, but high leverage and declining equity are concerns. Technical indicators suggest positive momentum, while valuation remains a challenge due to ongoing losses. The earnings call highlights strategic initiatives and refinancing efforts, providing a balanced but cautious outlook.

To see Spark’s full report on TSE:CL stock, click here.

More about Cresco Labs

Cresco Labs is a leading company in the cannabis industry, focusing on cultivation, production, and branded product distribution. It aims to normalize and professionalize the cannabis industry through a consumer packaged goods approach, building national brands and providing a customer-focused retail experience. The company operates dispensaries under the Sunnyside brand and is committed to community engagement and legislative initiatives to support the industry’s growth.

Average Trading Volume: 419,220

Technical Sentiment Signal: Sell

Current Market Cap: C$625.4M

For a thorough assessment of CL stock, go to TipRanks’ Stock Analysis page.